MIRALUMA Drug Patent Profile
✉ Email this page to a colleague
When do Miraluma patents expire, and when can generic versions of Miraluma launch?
Miraluma is a drug marketed by Lantheus Medcl and is included in one NDA.
The generic ingredient in MIRALUMA is technetium tc-99m sestamibi kit. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the technetium tc-99m sestamibi kit profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIRALUMA?
- What are the global sales for MIRALUMA?
- What is Average Wholesale Price for MIRALUMA?
Summary for MIRALUMA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 1 |
Patent Applications: | 36 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MIRALUMA at DailyMed |
![MIRALUMA drug patent expirations Drug patent expirations by year for MIRALUMA](/p/graph/s/t/MIRALUMA-patent-expirations.png)
Recent Clinical Trials for MIRALUMA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GE Healthcare | Early Phase 1 |
M.D. Anderson Cancer Center | Early Phase 1 |
National Cancer Institute (NCI) | Early Phase 1 |
US Patents and Regulatory Information for MIRALUMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lantheus Medcl | MIRALUMA | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 019785-003 | May 23, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MIRALUMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lantheus Medcl | MIRALUMA | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 019785-003 | May 23, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Lantheus Medcl | MIRALUMA | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 019785-003 | May 23, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Lantheus Medcl | MIRALUMA | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 019785-003 | May 23, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Lantheus Medcl | MIRALUMA | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 019785-003 | May 23, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Lantheus Medcl | MIRALUMA | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 019785-003 | May 23, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MIRALUMA
See the table below for patents covering MIRALUMA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 1218666 | COMPLEXE D'ISONITRILE ET D'ISOTOPES RADIOACTIFS POUR LE MARQUAGE D'AGENTS DE VISUALISATION MEDICALE (ISONITRILE RADIONUCLIDE COMPLEXES FOR LABELLING AND IMAGING AGENTS) | ⤷ Sign Up |
European Patent Office | 0211424 | METAL-ISONITRILE ADDUCTS FOR PREPARING RADIONUCLIDE COMPLEXES | ⤷ Sign Up |
European Patent Office | 0233368 | ETHER ISONITRILES AND RADIOLABELED COMPLEXES THEREOF | ⤷ Sign Up |
Portugal | 83136 | PROCESSO PARA A PREPARACAO DE COMPLEXOS DE RADIONUCLIDEOS MEDIANTE UTILIZACAO DE ADUCTOS DE METAL-ISONITRILO | ⤷ Sign Up |
U.S.S.R. | 1635903 | CПOCOБ ПOЛУЧEHИЯ TC-KOMПЛEKCA (PROCESS FOR PREPARING TC-COMPLEXES) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for MIRALUMA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0107734 | 93C0042 | Belgium | ⤷ Sign Up | PROD. NAME TETRAKIS (2-METHOXY-ISOBUTYL-ISONITRILE). CUIVRE (I) TETRAFLUOROBORATE, DIHYDRATE DE CHLORURE STANNEUX, CHLORHYDRATE DE L-CYSTEINE (MONOHYDRATE); REG NO/DATE 923 IS 3 F 12/ 19900924 ; FIRST REG CC NO DATE IE PA 200/9/1 19900817 |
0107734 | SPC/GB93/166 | United Kingdom | ⤷ Sign Up | SPC/GB93/166, EXPIRES: 20050816 |
1178838 | 300736 | Netherlands | ⤷ Sign Up | PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |